Adastra Labs Holdings Ltd. (TSE:XTRX) has released an update.
Adastra Holdings Ltd., a prominent Canadian cannabis processor, has announced plans to cease its reporting obligations to the U.S. Securities and Exchange Commission (SEC) by submitting a Form 15F, citing the costs outweigh the benefits. The company’s common shares will still be traded on the Canadian Securities Exchange and will meet Canadian disclosure requirements, with information available on SEDAR+. Adastra, known for its cannabis concentrates available at over 2,000 locations in Canada, will maintain its focus on product innovation and medical market applications.
For further insights into TSE:XTRX stock, check out TipRanks’ Stock Analysis page.
